ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Plasma from Patients with Primary Focal Segmental Glomerulosclerosis Induce Development of Sclerotic Glomeruli in Kidney Organoids

A. Kumar Gupta1, E. Minocha1, J. A. Wertheim1, L. Gallon2

1Department of Surgery, University of Arizona College of Medicine, Tucson, AZ, 2Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

Meeting: 2022 American Transplant Congress

Abstract number: 183

Keywords: Bioengineering, Glomerulonephritis, Renal injury, Stem cells

Topic: Basic Science » Basic Science » 06 - Tissue Engineering and Regenerative Medicine

Session Information

Session Name: Cellular/Islet Therapies and Tissue Engineering

Session Type: Rapid Fire Oral Abstract

Date: Sunday, June 5, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 6:40pm-6:50pm

Location: Hynes Room 310

*Purpose: Primary focal segmental glomerulosclerosis (FSGS) is a kidney disorder resulting in end-stage renal disease that is associated with an elevated rate of recurrence after renal transplantation. Etiology and pathogenesis of primary FSGS has not been well elucidated due to lack of appropriate preclinical models to study this complex disease, but different permeability factors circulating in plasma of patients with primary FSGS have been described. In recent years, procedures have been developed to differentiate human pluripotent stem cells (hPSCs) into renal tissues, which led us to investigate the effect of FSGS plasma during the development of kidney organoids.

*Methods: hPSCs were induced to differentiate into kidney progenitor cells by CHIR for 4 days, Activin for 3 days, and FGF 9 for 2 days. On day 9, progenitors were aggregated at the air-liquid interface and cultured in organoid media (containing BMP7, FGF9 and heparin) alone or in media containing 10% healthy plasma, recurrent FSGS plasma, non-recurrent FSGS plasma, or primary FSGS plasma. On day 16, organoids were evaluated under a stereomicroscope and stained for podocytes, CD44, and extracellular matrix (ECM) proteins produced by parietal epithelial cells (PECs).

*Results: Kidney organoids generated with organoid media or healthy plasma showed a typical developmental phenotype with intact and tightly packed tubular clusters, whereas organoids generated with FSGS plasma showed abnormal or damaged tubular clusters. Podocalyxin staining for podocytes showed that organoids generated in organoid media or healthy plasma had intact presumptive glomerular structures. Recurrent FSGS plasma treated organoids showed damaged presumptive glomerular structures, whereas non-recurrent or primary FSGS plasma treated organoids had a scattered podocalyxin staining pattern. Furthermore, a high ECM protein deposition and a high CD44 expression were observed in the glomerular basement membrane (GBM) of FSGS plasma treated organoids, whereas organoid media or healthy plasma led to a normal ECM protein expression and no expression of CD44 in their GBM.

*Conclusions: This study shows that primary FSGS plasma can trigger an abnormal kidney organoid development with a FSGS specific abnormality in glomerular structures and podocytes. Additionally, CD44+ activated glomerular PECs produce more ECM proteins that deposit on GBM and induce sclerotic glomerular development. In conclusion, the kidney organoid model could be a useful tool to study the pathophysiology and disease progression of primary FSGS.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Gupta AKumar, Minocha E, Wertheim JA, Gallon L. Plasma from Patients with Primary Focal Segmental Glomerulosclerosis Induce Development of Sclerotic Glomeruli in Kidney Organoids [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/plasma-from-patients-with-primary-focal-segmental-glomerulosclerosis-induce-development-of-sclerotic-glomeruli-in-kidney-organoids/. Accessed May 17, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences